Thursday, June 11, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 73 of 1,261
  1. US 12180258

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  2. US 12178921

    Method of lyophilizing lipid nanoparticles

    ARCTURUS THERAPEUTICS, INC. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  3. US 12178909

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  4. US 12179037

    Radiotherapies and uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  5. US 12180084

    Cerium (III) carbonate formulations

    The Regents of the University of California · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  6. US 12178875

    Lymphatic system-directing lipid prodrugs

    Seaport Therapeutics, Inc. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  7. US 12178981

    Drug administration method

    Takeda Pharmaceutical Company Limited · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  8. US 12178868

    Immunogenic compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  9. US 12178860

    Hyaluronidase enzyme formulations for high volume administration

    HALOZYME, INC. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  10. US 12178887

    NIR-conjugated tumor-specific antibodies and uses thereof

    The Regents of the University of California · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  11. US 12180206

    Aceclidine derivatives, compositions thereof and methods of use thereof

    LENZ THERAPEUTICS OPERATIONS, INC. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  12. US 12178861

    Stabilized liquid and lyophilized ADAMTS13 formulations

    Takeda Pharmaceutical Company Limited · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  13. US 12178811

    Methods of treating depressive disorders

    Xenon Pharmaceuticals Inc. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  14. US 12178626

    Encapsulated gas or partial vacuum CT contrast material

    United States Government as represented by the Department of Veterans Affairs · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  15. US 12180251

    Nucleic acids encoding peptides that block binding of a2d-1 to glutamate receptors for treating diseases and disorders

    The Board of Regents of the University of Texas System · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  16. US 12178787

    T cell receptors for immunotherapy

    The Board of Regents of the University of Texas System · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  17. US 12180471

    Antisense oligonucleotides for the treatment of Stargardt disease

    ProQR Therapeutics II B.V. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  18. US 12178848

    Methods and compositions for the treatment of exocrine pancreatic insufficiency

    The Board of Regents of the University of Texas System · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  19. WO 2024261235

    PROTÉINES CHIMÉRIQUES POUR MODULER L'ACTIVITÉ D'UN RÉCEPTEUR DE CYTOKINE

    ABLYNX NV [BE] · Granted Dec 26, 2024 · Expires Dec 21, 2044

    granted
  20. WO 2024261256

    COMPOSITION PHARMACEUTIQUE COMPRENANT UN AGENT DE DÉGRADATION PAN-KRAS

    ASTELLAS PHARMA INC [JP] · Granted Dec 26, 2024 · Expires Dec 21, 2044

    granted
  21. US 12173089

    Inhibition of pulmonary fibrosis with nutlin-3A and peptides

    The Board of Regents of the University of Texas System · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  22. US 12171750

    Isoxazoline parasiticide formulations and methods for treating blepharitis

    Tarsus Pharmaceuticals, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  23. US 12173289

    Hepatitis B virus (HBV) dsRNA agent compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  24. US 12171777

    Methods of making a cyclic dinucleotide

    Takeda Pharmaceutical Company Limited · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.